Cultivar Capital’s Cardinal Health CAH Stock Holding History

Cultivar Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-273	Closed	-$26.8K	–	51
2024 Q2	$26.8K	Buy	+273	New	+$27.8K	0.02%	89

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cultivar Capital's CAH Position: Q3 2024 in Review

Cultivar Capital sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 273 shares — an estimated $26.8K sold.

Cultivar Capital first reported a position in CAH in Q2 2024 and held it in 1 quarter. The position peaked at $26.8K in Q2 2024. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

Cultivar Capital reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
Cultivar Capital sold 273 Cardinal Health shares in Q3 2024, an estimated $26.8K.
Cultivar Capital first reported a position in Cardinal Health in Q2 2024 and held it in 1 quarter.
Cultivar Capital's Cardinal Health position peaked at $26.8K in Q2 2024.
1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Cultivar Capital's 13F filing for Q3 2024, filed 16 Oct 2024.